These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28382609)

  • 1. Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.
    Rubinsztajn R; Przybyłowski T; Maskey-Warzęchowska M; Paplińska-Goryca M; Nejman-Gryz P; Karwat K; Chazan R
    Adv Exp Med Biol; 2017; 1021():55-62. PubMed ID: 28382609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease.
    Manganas H; Lacasse Y; Bourgeois S; Perron J; Dagenais F; Maltais F
    Can Respir J; 2007; 14(1):19-24. PubMed ID: 17315054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Tommola M; Ilmarinen P; Tuomisto LE; Lehtimäki L; Haanpää J; Niemelä O; Kankaanranta H
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis.
    Plesner LL; Warming PE; Nielsen TL; Dalsgaard M; Schou M; Høst U; Rydahl C; Brandi L; Køber L; Vestbo J; Iversen K
    Hemodial Int; 2016 Jan; 20(1):68-77. PubMed ID: 26245152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
    Fowkes FG; Anandan CL; Lee AJ; Smith FB; Tzoulaki I; Rumley A; Powell JT; Lowe GD
    J Vasc Surg; 2006 Mar; 43(3):474-80. PubMed ID: 16520158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities of COPD in Bulgarian Patients - Prevalence and Association with Severity and Inflammation.
    Stratev V; Petkova D; Dimitrova V; Petev J
    Folia Med (Plovdiv); 2018 Mar; 60(1):102-109. PubMed ID: 29668450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.
    Ban WH; Kang HH; Kim IK; Ha JH; Joo H; Lee JM; Lim JU; Lee SH; Rhee CK
    Korean J Intern Med; 2018 Jul; 33(4):745-752. PubMed ID: 29529843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.
    Saleh HZ; Mohan K; Shaw M; Al-Rawi O; Elsayed H; Walshaw M; Chalmers JA; Fabri BM
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):108-13; discussion 113. PubMed ID: 22290913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
    Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
    Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.